AAAAAA

   
Results: 1-21 |
Results: 21
Detection of chromosome abnormalities pre-high-dose treatment in patients developing therapy-related myelodysplasia and secondary acute myelogenous leukemia after treatment for non-Hodgkin's lymphoma
Authors: Lillington, DM Micallef, INM Carpenter, E Neat, MJ Amess, JAL Matthews, J Foot, NJ Young, BD Lister, TA Rohatiner, AZS
Citation: Dm. Lillington et al., Detection of chromosome abnormalities pre-high-dose treatment in patients developing therapy-related myelodysplasia and secondary acute myelogenous leukemia after treatment for non-Hodgkin's lymphoma, J CL ONCOL, 19(9), 2001, pp. 2472-2481
Lung cancer after Hodgkin's disease: A nested case-control study of the relation to treatment
Authors: Swerdlow, AJ Schoemaker, MJ Allerton, R Horwich, A Barber, JA Cunningham, D Lister, TA Rohatiner, AZS Hudson, GV Williams, MV Linch, DC
Citation: Aj. Swerdlow et al., Lung cancer after Hodgkin's disease: A nested case-control study of the relation to treatment, J CL ONCOL, 19(6), 2001, pp. 1610-1618
Loss of CD20 expression following treatment with rituximab (chimaeric monoclonal anti-CD20): a retrospective cohort analysis
Authors: Foran, JM Norton, AJ Micallef, INM Taussig, DC Amess, JAL Rohatiner, AZS Lister, TA
Citation: Jm. Foran et al., Loss of CD20 expression following treatment with rituximab (chimaeric monoclonal anti-CD20): a retrospective cohort analysis, BR J HAEM, 114(4), 2001, pp. 881-883
Long-term outcome of patients surviving for more than ten years following treatment for acute leukaemia
Authors: Micallef, INM Rohatiner, AZS Carter, M Boyle, M Slater, S Amess, JAL Lister, TA
Citation: Inm. Micallef et al., Long-term outcome of patients surviving for more than ten years following treatment for acute leukaemia, BR J HAEM, 113(2), 2001, pp. 443-445
Serum LDH, a prognostic factor in elderly patients with acute myelogenous leukaemia
Authors: Dalley, CD Lister, TA Cavenagh, JD Rohatiner, AZS
Citation: Cd. Dalley et al., Serum LDH, a prognostic factor in elderly patients with acute myelogenous leukaemia, BR J CANC, 84(1), 2001, pp. 147-147
Early application of anthracyclines in adult acute lymphoblastic leukemia (ALL)
Authors: Bassan, R Rohatiner, AZS Lerede, T Carter, M Di Bona, E Pogliani, E Rossi, G Fabris, P Morandi, S Lambertenghi-Deliliers, G Casula, P Vespignani, M Lister, TA Barbui, T
Citation: R. Bassan et al., Early application of anthracyclines in adult acute lymphoblastic leukemia (ALL), HEMAT BLOOD, 40, 2001, pp. 402-413
High-dose treatment with autologous bone marrow support as consolidation of first remission in younger patients with acute myelogenous leukaemia
Authors: Rohatiner, AZS Bassan, R Raimondi, R Amess, JAL Arnott, S Personen, A Rodeghiero, F Barbui, T Bradburn, MJ Carter, M Lister, TA
Citation: Azs. Rohatiner et al., High-dose treatment with autologous bone marrow support as consolidation of first remission in younger patients with acute myelogenous leukaemia, ANN ONCOL, 11(8), 2000, pp. 1007-1015
Low-dose continuous chemotherapy (LBCMVD-56) for refractory and relapsing lymphoma
Authors: Shamash, J Walewski, J Apostolidis, J Wilson, AM Foran, JM Gupta, RK Rohatiner, AZS Kelsey, SM Lister, TA
Citation: J. Shamash et al., Low-dose continuous chemotherapy (LBCMVD-56) for refractory and relapsing lymphoma, ANN ONCOL, 11(7), 2000, pp. 857-860
A phase II study to evaluate the combination of fludarabine, mitoxantrone and dexamethasone (FMD) in patients with follicular lymphoma
Authors: Crawley, CR Foran, JM Gupta, RK Rohatiner, AZS Summers, K Matthews, J Micallef, INM Radford, JA Johnson, SA Johnson, PW Sweetenham, JW Lister, TA
Citation: Cr. Crawley et al., A phase II study to evaluate the combination of fludarabine, mitoxantrone and dexamethasone (FMD) in patients with follicular lymphoma, ANN ONCOL, 11(7), 2000, pp. 861-865
Patterns of relapse and subsequent management following high-dose chemotherapy with autologous haematopoietic support in relapsed or refractory Hodgkin's lymphoma: A two centre study
Authors: Shamash, J Lee, SM Radford, JA Rohatiner, AZS Chang, J Morgenstern, GR Scarffe, JH Deakin, DP Lister, TA
Citation: J. Shamash et al., Patterns of relapse and subsequent management following high-dose chemotherapy with autologous haematopoietic support in relapsed or refractory Hodgkin's lymphoma: A two centre study, ANN ONCOL, 11(6), 2000, pp. 715-719
Therapy-related myelodysplasia and secondary acute myelogenous leukemia after high-dose therapy with autologous hematopoietic progenitor-cell supportfor lymphoid malignancies
Authors: Micallef, INM Lillington, DM Apostolidis, J Amess, JAL Neat, M Matthews, J Clark, T Foran, JM Salam, A Lister, TA Rohatiner, AZS
Citation: Inm. Micallef et al., Therapy-related myelodysplasia and secondary acute myelogenous leukemia after high-dose therapy with autologous hematopoietic progenitor-cell supportfor lymphoid malignancies, J CL ONCOL, 18(5), 2000, pp. 947-955
High-dose therapy with autologous bone marrow support as consolidation of remission in follicular lymphoma: Long-term clinical and molecular follow-up
Authors: Apostolidis, J Gupta, RK Grenzelias, D Johnson, PWM Pappa, VI Summers, KE Salam, A Adams, K Norton, AJ Amess, JAL Matthews, J Bradburn, M Lister, TA Rohatiner, AZS
Citation: J. Apostolidis et al., High-dose therapy with autologous bone marrow support as consolidation of remission in follicular lymphoma: Long-term clinical and molecular follow-up, J CL ONCOL, 18(3), 2000, pp. 527-536
European phase II study of rituximab (chimeric anti-CD20 monoclonal antibody) for patients with newly diagnosed mantle-cell lymphoma and previously treated mantle-cell lymphoma, immunocytoma, and small B-cell lymphocytic lymphoma
Authors: Foran, JM Rohatiner, AZS Cunningham, D Popescu, RA Solal-Celigny, P Ghielmini, M Coiffier, B Johnson, PWM Gisselbrecht, C Reyes, F Radford, JA Bessell, EM Souleau, B Benzohra, A Lister, TA
Citation: Jm. Foran et al., European phase II study of rituximab (chimeric anti-CD20 monoclonal antibody) for patients with newly diagnosed mantle-cell lymphoma and previously treated mantle-cell lymphoma, immunocytoma, and small B-cell lymphocytic lymphoma, J CL ONCOL, 18(2), 2000, pp. 317-324
A UK multicentre phase II study of rituximab (chimaeric anti-CD20 monoclonal antibody) in patients with follicular lymphoma, with PCR monitoring of molecular response
Authors: Foran, JM Gupta, RK Cunningham, D Popescu, RA Goldstone, AH Sweetenham, JW Pettengell, R Johnson, PWM Bessell, E Hancock, B Summers, K Hughes, J Rohatiner, AZS Lister, TA
Citation: Jm. Foran et al., A UK multicentre phase II study of rituximab (chimaeric anti-CD20 monoclonal antibody) in patients with follicular lymphoma, with PCR monitoring of molecular response, BR J HAEM, 109(1), 2000, pp. 81-88
Acute promyelocytic leukaemia: a retrospective analysis of patients treated at St. Bartholomew's Hospital 1969-1995
Authors: Slater, S Carter, M Howe, K Amess, J Rohatiner, AZS Lister, TA
Citation: S. Slater et al., Acute promyelocytic leukaemia: a retrospective analysis of patients treated at St. Bartholomew's Hospital 1969-1995, ANN HEMATOL, 78(3), 1999, pp. 131-137
CT appearances of mucosa-associated lymphoid tissue (MALT) lymphoma
Authors: Kessar, P Norton, A Rohatiner, AZS Lister, TA Reznek, RH
Citation: P. Kessar et al., CT appearances of mucosa-associated lymphoid tissue (MALT) lymphoma, EUR RADIOL, 9(4), 1999, pp. 693-696
Immunocytoma: A retrospective analysis from St Bartholomew's Hospital - 1972 to 1996
Authors: Papamichael, D Norton, AJ Foran, JM Mulatero, C Mathews, J Amess, JAL Bradburn, M Lister, TA Rohatiner, AZS
Citation: D. Papamichael et al., Immunocytoma: A retrospective analysis from St Bartholomew's Hospital - 1972 to 1996, J CL ONCOL, 17(9), 1999, pp. 2847-2853
Multicenter phase II study of fludarabine phosphate for patients with newly diagnosed lymphoplasmacytoid lymphoma, Waldenstrom's macroglobulinemia, and mantle-cell lymphoma
Authors: Foran, JM Rohatiner, AZS Coiffier, B Barbui, T Johnson, SA Hiddemann, W Radford, JA Norton, AJ Tollerfield, SM Wilson, MP Lister, TA
Citation: Jm. Foran et al., Multicenter phase II study of fludarabine phosphate for patients with newly diagnosed lymphoplasmacytoid lymphoma, Waldenstrom's macroglobulinemia, and mantle-cell lymphoma, J CL ONCOL, 17(2), 1999, pp. 546-553
Patterns of outcome following recurrence after myeloablative therapy with autologous bone marrow transplantation for follicular lymphoma
Authors: Apostolidis, J Foran, JM Johnson, PWM Norton, A Amess, J Matthews, J Bradburn, M Lister, TA Rohatiner, AZS
Citation: J. Apostolidis et al., Patterns of outcome following recurrence after myeloablative therapy with autologous bone marrow transplantation for follicular lymphoma, J CL ONCOL, 17(1), 1999, pp. 216-221
Monoclonal Epstein-Barr virus-related lymphoproliferative disorder following adult acute lymphoblastic leukaemia
Authors: Foran, JM Slater, SE Norton, AJ Wilkes, SJ Hart, IJ Rohatiner, AZS
Citation: Jm. Foran et al., Monoclonal Epstein-Barr virus-related lymphoproliferative disorder following adult acute lymphoblastic leukaemia, BR J HAEM, 106(3), 1999, pp. 713-716
Peripheral T-cell lymphoma following Rituximab therapy for B-cell lymphoma
Authors: Micallef, INM Kirk, A Norton, A Foran, JM Rohatiner, AZS Lister, TA
Citation: Inm. Micallef et al., Peripheral T-cell lymphoma following Rituximab therapy for B-cell lymphoma, BLOOD, 93(7), 1999, pp. 2427-2428
Risultati: 1-21 |